Physician profile
Sarwar Orakzai
NPI 1295901270
$125,807.75
in general payments reported to CMS, 2019-2025
8 companies · $6,623 in 2025
The $6,623 reported for 2025 was more than what 93% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $52K · 2021: $7,460 · 2022: $18K · 2023: $14K · 2024: $13K · 2025: $6,623.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $24K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $5,853 · Travel and Lodging: $3,400 · Food and Beverage: $605 · Consulting Fee: $128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $23,680.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $5,852.50 |
| Travel and Lodging | $3,400.20 |
| Food and Beverage | $605.19 |
| Consulting Fee | $127.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $108,998.73 | 2019-2025 | (1658) Clinical Educ Ultrasound, Clinical Educ Ultrasound, (1658) Clin Educ US |
| Lantheus Medical Imaging, INC. | $13,455.28 | 2019-2021 | |
| Boston Scientific Corporation | $1,688.46 | 2019-2024 | Watchman Flx |
| Heartflow, INC. | $1,291.42 | 2020-2023 | Ffrct |
| Abbott Laboratories | $222.36 | 2020-2023 | Mitraclip |
| Alnylam Pharmaceuticals INC. | $101.94 | 2019 | |
| Edwards Lifesciences Corporation | $32.63 | 2023 | Pascal |
| Janssen Pharmaceuticals, INC | $16.93 | 2024 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarwar Orakzai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.